Arrowhead Research « Terug naar discussie overzicht

Forum Arrowhead Research geopend

8.702 Posts, Pagina: « 1 2 3 4 5 6 ... 431 432 433 434 435 436 | Laatste
Omlaag ↓
Gerard1968 10 februari 2025 14:47
0
Lid sinds: 24 jul 2006
Laatste bezoek: 10 feb 2025
Aantal posts:
106
Aanbevelingen:
Ontvangen: 67
Gegeven: 7662
Officiële bevestiging dat de deal met Sarepta rond is:

ir.arrowheadpharma.com/news-releases/...
DeZwarteRidder 10 februari 2025 14:50
1
Lid sinds: 29 jun 2012
Laatste bezoek: 10 feb 2025
Aantal posts:
101.989
Aanbevelingen:
Ontvangen: 24091
Gegeven: 10531
quote:

Gerard1968 schreef op 10 februari 2025 14:47:

ir.arrowheadpharma.com/news-releases/...
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics
February 10, 2025
PDF Version

PASADENA, Calif.--(BUSINESS WIRE)--Feb. 10, 2025-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT) announced on November 26, 2024, has now closed. Closing of the transaction was subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and other customary conditions.

Summary Financial Terms

Upon closing, Arrowhead receives a $500 million upfront payment and $325 million through the purchase by Sarepta of Arrowhead common stock priced at $27.25 per share. Arrowhead will also receive $250 million to be paid in annual installments of $50 million over 5 years. Arrowhead also has the potential to receive $300 million in near-term payments associated with the continued enrollment of certain cohorts of a Phase 1/2 study of ARO-DM1, which Arrowhead is on track to achieve during the next 12 months.

Arrowhead is eligible to receive development milestone payments of between $110 million and $410 million per program and sales milestone payments of between $500 million and $700 million per program. Arrowhead is also eligible to receive tiered royalties on commercial sales up to the low double digits.
8.702 Posts, Pagina: « 1 2 3 4 5 6 ... 431 432 433 434 435 436 | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 10 feb 2025 22:00
Koers 19,920
Verschil -0,320 (-1,58%)
Hoog 20,480
Laag 19,370
Volume 1.503.018
Volume gemiddeld 2.031.446
Volume gisteren 1.224.753

Arrowhead Pharmaceuticals nieuws meer

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront